AI-Driven bioX Genetics Platform Slashes Genetic Variant Detection Time

Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors

BioNTech and BMS Forge Partnership to Advance BNT327 for Solid Tumors

Merck Expands US Bio Manufacturing with $1B Wilmington Facility for KEYTRUDA

Boehringer and Tessellate Partner to Develop Treatments for Hard-to-Treat Cancers

Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases

AbbVie Acquires Nimble in $200 Million Deal to Strengthen Immunology Pipeline

General Inception Acquires Enable Medicine to Drive AI-Led Drug Discovery

Elevation Partners with Synaffix in $368M Deal to Advance HER3 ADC Development

Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation

Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan

Flindr Receives €20 Million to Advance Precision Cancer Treatments with RNF31 Inhibitor

AstraZeneca's $2.4 Billion Strategic Move: Acquiring Fusion for Radiopharmaceutical

Gilead and Merus Forge $1.5 Billion Oncology Alliance to Novel Cancer Treatments

The Global CAR T-Cell Therapy Market's Ascent: From $8.2 B in 2022 to $11.2 B by 2030

J&J's $2 Billion Strategic Acquisition of Ambrx Biopharma: Leading in ADC Oncology

Scemblix Outperforms Standard TKIs in Phase III Chronic Myeloid Leukemia Trial

Merck's $680 Million Strategic Move to Boost Oncology Pipeline with Harpoon Acquisition

Novartis Launches Its Largest RLT Facility in Indianapolis, Enhancing Pluvicto Production

AbbVie and Umoja Collaborate to Advance CAR-T Cell Therapy

Boehringer Ingelheim Partners with Ribo for Liver Disease Therapies in $2 Billion Deal

Boehringer Ingelheim and 3T Forge Alliance to Advance Cancer Immunotherapies

Novo Nordisk, Omega and Cellarity Collaborate to Reshape Future of Obesity and MASH

Roche and MediLink Collaborate to Develop Next-Generation Cancer Drug YL211

Bloodstream Infection Treatment: Phase 3 Trial of Mino-Lok Completed

Novartis and Voyager Enter Strategic Collaboration to Advance Novel Gene Therapies

Astellas and Elpiscience Collaborate on Bispecific Macrophage Engager for Cancer Research

Bristol Myers Squibb Expands Oncology Line with $4.1 Billion RayzeBio Acquisition

Strategic Leap in Neuropharma: Bristol Myers' $14 Billion Acquisition of Karuna